GOSS: Gossamer Bio, Inc. Stock

by  •  • Comments Off on GOSS: Gossamer Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 188.62
Enterprise Value ($M) 340.07
Book Value ($M) 29.49
Book Value / Share 0.13
Price / Book 6.40
NCAV ($M) 24.09
NCAV / Share 0.11
Price / NCAV 7.83

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.22
Return on Equity (ROE) -2.12

Liquidity (mrq)
Quick Ratio 6.88
Current Ratio 6.88

Balance Sheet (mrq) ($M)
Current Assets 309.89
Assets 315.29
Liabilities 285.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 114.70
Operating Income -59.92
Net Income -56.53
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -3.47
Cash from Investing 29.02
Cash from Financing -11.49

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Invus Global Management, LLC 2.80 -56.33
02-05 13G Octagon Capital Advisors LP 8.60
01-30 13G/A Vanguard Group Inc 4.42 -13.76
11-12 13G/A Fmr Llc 3.51 -35.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-07 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q – UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 191,881 634,175 30.26
2025-04-16 374,140 948,867 39.43
2025-04-15 225,985 894,925 25.25
2025-04-14 189,768 750,434 25.29

(click for more detail)

Similar Companies
GERN – Geron Corporation GILD – Gilead Sciences, Inc.
GLUE – Monte Rosa Therapeutics, Inc. HALO – Halozyme Therapeutics, Inc.
HLVX – HilleVax, Inc.


Financial data and stock pages provided by
Fintel.io